Involvement of the Fhit gene in the ionizing radiation-activated ATR/CHK1 pathway

Journal of Cellular Physiology
Baocheng HuYa Wang

Abstract

Fragile Histidine Triad (Fhit) gene deletion, methylation, and reduced Fhit protein expression occur in about 70% of human epithelial tumors and, in some cancers, are clearly associated with tumor progression. Specific Fhit signal pathways have not been identified, although it has been shown that Fhit overexpression leads to apoptosis in many cancer cell lines. We report in this study that Fhit-/- cells derived from gene knockout mice show much stronger S and G2 checkpoint responses than their wild type counterparts. The strong checkpoint responses are regulated by the ATR/CHK1 pathway, which contributes to the radioresistance of Fhit-/- cells. These results indicate an association of Fhit gene inactivation with increased survival after DNA damage, which is related to the over-active checkpoints regulated by the ATR/CHK1 pathway. These results also suggest the potential effects of Fhit-dependent DNA damage response on tumor progression.

References

Dec 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R B Painter, B R Young
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·M S EllerB A Gilchrest
Feb 7, 1997·Cell·A G PaulovichL H Hartwell
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·F LiangM Jasin
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·J A WrightP Concannon
Dec 19, 1998·The EMBO Journal·R G MartinhoN J Bentley
Apr 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·L Y FongK Huebner
Dec 2, 2000·Nature·B B Zhou, S J Elledge
Mar 30, 2001·The Journal of Biological Chemistry·B HuY Wang
Apr 21, 2001·Molecular and Cellular Biology·B XuM B Kastan
May 30, 2001·Mutation Research·L H Thompson, D Schild
Jun 8, 2001·Molecular and Cellular Biology·H Zhao, H Piwnica-Worms
Aug 17, 2001·Mutation Research·A PastinkP H Lohman
Sep 7, 2001·Genes & Development·R T Abraham
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·A Lopez-GironaP Russell
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·P B DemingW K Kaufmann
Jan 26, 2002·Molecular and Cellular Biology·Bo XuMichael B Kastan
Oct 26, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hui ZhaoHelen Piwnica-Worms
May 29, 2003·British Journal of Cancer·K Huebner, C M Croce
Oct 21, 2004·British Journal of Cancer·M OtteyK Huebner

❮ Previous
Next ❯

Citations

Jun 30, 2011·Cancer Biotherapy & Radiopharmaceuticals·Yu-Xiang LinBao-Cheng Hu
Apr 11, 2013·Cancer Biotherapy & Radiopharmaceuticals·Jipo ShengBaocheng Hu
Apr 28, 2009·International Immunology·Haibing ZhangJianke Zhang
Oct 8, 2009·Nucleic Acids Research·Shuang LiuYa Wang
Dec 18, 2008·Future Oncology·Flavia PichiorriCarlo M Croce
Apr 30, 2009·International Journal of Radiation Biology·Lin LuYa Wang
Oct 26, 2005·Cancer Letters·Louise V O'Keefe, Robert I Richards
Dec 5, 2006·Seminars in Cancer Biology·David I SmithDamon S Perez
Feb 27, 2008·Virchows Archiv : an International Journal of Pathology·Naoki YanagawaTeiichi Motoyama
Apr 9, 2008·Journal of Cellular Biochemistry·Flavia PichiorriKay Huebner
Jan 19, 2010·Journal of Cellular Biochemistry·Joshua C SaldivarKay Huebner
Oct 19, 2005·International Journal of Cancer. Journal International Du Cancer·Cheol Hyeon KimChul-Gyu Yoo
Mar 21, 2006·Journal of Cellular Physiology·Manuela CampiglioLuca Roz
Jun 3, 2009·Cancer Science·Hiroshi OkumuraKay Huebner
Jul 28, 2017·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Aman KhuranaEric T Ahrens
Oct 21, 2004·British Journal of Cancer·M OtteyK Huebner
Oct 6, 2005·Cancer Research·Baocheng HuYa Wang
Dec 6, 2006·Cancer Research·Hideshi IshiiKay Huebner
Apr 2, 2008·Cancer Letters·Sergiy KvashaAlexandr F Vozianov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis